FRI0096 Influence of dose titration of concomitant steroid and methotrexate during biologic therapy on remission rates in patients with rheumatoid arthritis according to the new ACR/EULAR remission criteria in daily practice based on the iorra cohort

Abstract

BackgroundAfter the introduction of biologics for the treatment of patients with active rheumatoid arthritis (RA), clinical remission has become an achievable and realistic therapeutic goal. In clinical trials, remission rates...